A study finds improvement in the proportion of scientific projects that include both sexes, but analyzing results by sex is not routine.

Staff at the UK’s Harwell Institute were notified that a strategy board recommended halting its academic work, but a final decision is months away.

A drive for revenue is damaging basic science.

Despite the Human Genome Project having heralded the exploration of previously unknown human genes, the focus of genetic studies remains narrow.

With multiple applications in biomedicine, the antibodies can now be made quickly, cheaply, and without the need for an alpaca or one of its relatives.

Nineteen researchers have stepped down after the journal decided not to retract a paper that they say plagiarized the work of a Johns Hopkins biomedical scientist.

Mentoring is critical for students just beginning to learn the ropes of biomedical research.

The Scripps Research Institute will join forces with the California Institute for Biomedical Research.

It is unethical to admit increasing numbers of students to graduate programs without considering the realities of the job market.

Following an independent group’s finding of misreported outcomes, the Annals of Internal Medicine now requires that authors include clinical trial protocols when submitting their results.

Study reveals trends in the frequency of female first authors on medical studies.

The nonprofit institution names a new CEO and president.

Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.

The technology company is launching a new data-sharing platform that it says can make any iPhone user a medical research participant. But the associated ethics are anything but simple.

Award recognizes research that has improved outcomes for premature babies.

Assistant Professor, Biomedical Engineering, Boston University. Age: 37

The next big thing in medical research is to more comprehensively evaluate its impact.

Crowds flooded into a Washington, DC, park to protest NIH budget cuts and rally for greater investment in potentially life-saving biomedical research. 

Academic research universities and cancer centers will have a large hunk of their funding cut because of the government sequester.